Title : Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.

Pub. Date : 2019 Feb 26

PMID : 30733293






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The cannabinoid Delta9-tetrahydrocannabinol (THC) disrupts HER2-CB2R complexes by selectively binding to CB2R, which leads to (i) the inactivation of HER2 through disruption of HER2-HER2 homodimers, and (ii) the subsequent degradation of HER2 by the proteasome via the E3 ligase c-CBL. Dronabinol Cbl proto-oncogene Homo sapiens
2 The cannabinoid Delta9-tetrahydrocannabinol (THC) disrupts HER2-CB2R complexes by selectively binding to CB2R, which leads to (i) the inactivation of HER2 through disruption of HER2-HER2 homodimers, and (ii) the subsequent degradation of HER2 by the proteasome via the E3 ligase c-CBL. Dronabinol Cbl proto-oncogene Homo sapiens